Stay updated on ACTIV-5/BET-C Trial: COVID-19 Treatment Clinical Trial
Sign up to get notified when there's something new on the ACTIV-5/BET-C Trial: COVID-19 Treatment Clinical Trial page.

Latest updates to the ACTIV-5/BET-C Trial: COVID-19 Treatment Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe study record is displayed with details of the remdesivir-and-danicopan trial, its results measures, participant criteria, and supporting documents.SummaryDifference91%

- Check21 days agoChange DetectedThe ClinicalTrials.gov site revision is now v3.8.0 instead of v3.7.2. The page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check27 days agoChange DetectedA site-wide NIH banner announces a transition from using “Artificial Intelligence” to “Super Intelligence” terminology.SummaryDifference1%

- Check34 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2 on the 403 Forbidden page.SummaryDifference0.2%

- Check41 days agoChange DetectedThe footer’s ClinicalTrials.gov revision label changes from v3.7.0 to v3.7.1, while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check62 days agoChange DetectedThe page now shows a 403 Forbidden error instead of the study content, presenting the standard 403 page with header/footer. This prevents access to the study record on that URL.SummaryDifference22%

Stay in the know with updates to ACTIV-5/BET-C Trial: COVID-19 Treatment Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ACTIV-5/BET-C Trial: COVID-19 Treatment Clinical Trial page.